Updated on 16 October 2012
TAP Biosystems to market automated systems in Australia and New Zealand
Singapore: UK-based TAP Biosystems has appointed Australia's TrendBio, a company that supplies high quality life science research products, in order to provide scientists in Australia and New Zealand with rapid access and support to TAP Biosystems' range of automated bioprocessing and cell processing technologies.
Under the terms of the agreements, TrendBio will exclusively market and support a range of TAP's market-leading products in Australia and New Zealand. These include AMBR (automated micro scale bioreactor), which mimics the characteristics of classical bioreactors at micro scale and RAFT (3D cell culture system) that generates consistent, reproducible collagen-based 3D cell cultures for drug screening applications.
The range of products also include Fill-It (automated dispensing into screw-cap cryovials), which maintains optimum cell quality when processing large batches of cryovials.
Mr Ian Ransome, director of commercial operations, Asia Pacific, TAP Biosystems, said that, "We are delighted TrendBio is our distribution partner because the company has an excellent reputation for marketing many leading life science equipment brands in Australia and New Zealand. This means scientists here can be assured of professional support for their systems from a dedicated team of technical sales specialists."
Mr Ransome added, "We look forward to meeting scientists at the BioProcessing Network Conference and to discussing how all of the products available through TrendBio will help them to enhance the quality of their research, as well as significantly improve the productivity of their bioprocessing or cell-based research and development programmes."